ContraFect Corp (CFRX)

NASDAQ
0.289
-0.011(-3.53%)
After Hours
0.290
+0.001(+0.277%)
- Real-time Data
  • Volume:
    2,705,790
  • Day's Range:
    0.289 - 0.302
  • 52 wk Range:
    0.288 - 4.530
Unusual trading volume

CFRX Overview

Prev. Close
0.3
Day's Range
0.289-0.302
Revenue
-
Open
0.3
52 wk Range
0.288-4.53
EPS
-0.895
Volume
2,705,790
Market Cap
11.38M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,272,268
P/E Ratio
-0.369
Beta
0.556
1-Year Change
-92.82%
Shares Outstanding
39,332,721
Next Earnings Date
11 Aug 2022
What is your sentiment on ContraFect Corp?
or
Market is currently closed. Voting is open during market hours.

ContraFect Corp News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

ContraFect Corp Company Profile

ContraFect Corp Company Profile

Employees
33

ContraFect Corporation is a late clinical-stage biotechnology company. The Company is focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lead DLA product candidate, exebacase (CF-301), is used for the treatment of methicillin-resistant S. aureus (MRSA) bloodstream infections (bacteremia), including right-sided endocarditis, when used in addition to standard-of-care (SOC) anti-staphylococcal antibiotics in adult patients. Its other product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa and has demonstrated potent in vivo activity against extensively drug-resistant (XDR) strains. It has developed an, engineered variant of exebacase, known as CF-296. It is conducting further in vitro and in vivo characterization of CF-296 to evaluate the full profile of this compound.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Going above $10 June 2022
    0